John L. Slebir's most recent trade in Dynavax Technologies Corp. was a trade of 16,667 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 16,667 | 41,731 (0%) | 0% | - | Common Stock | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 16,667 | 33,333 | - | - | Restricted Stock Unit | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.93 per share. | 18 Feb 2025 | 5,358 | 36,373 (0%) | 0% | 12.9 | 69,279 | Common Stock |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 42,424 | 42,424 | - | - | Restricted Stock Unit | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,000 | 28,397 (0%) | 0% | - | Common Stock | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,000 | 0 | - | - | Restricted Stock Unit | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 14,000 | 14,000 | - | - | Restricted Stock Unit | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.69 per share. | 13 Feb 2025 | 4,708 | 25,064 (0%) | 0% | 12.7 | 59,745 | Common Stock |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,666 | 16,144 (0%) | 0% | - | Common Stock | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,666 | 0 | - | - | Restricted Stock Unit | |
Dynavax Technologies Corp. | John L. Slebir | SVP General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 10 Feb 2025 | 1,747 | 14,397 (0%) | 0% | 13.2 | 23,060 | Common Stock |